Soligenix (SNGX) Revenue (2010 - 2024)
Soligenix's (SNGX) quarterly Revenue came in at $2342.0 in Q2 2024, down 98.87% on a YoY basis from $206929.0 in Q3 2023, and down 98.0% quarter-over-quarter from $117029.0 in Q1 2024.
Powered by 
Analysis
Soligenix (SNGX) Revenue (2010 - 2024) Analysis & Trends
Soligenix (SNGX) has reported Revenue for 15 consecutive years, with $2342.0 the latest figure, recorded in Q2 2024.
- For the quarter ending Q2 2024, Revenue fell 98.87% year-over-year to $2342.0; the trailing twelve-month figure through Dec 2024 stood at $119371.0 (down 85.78% YoY), and the FY2024 full-year result was $119371.0, down 85.78% from the prior year.
- Revenue declined to $2342.0 in Q2 2024 per SNGX's latest filing, from $117029.0 in the prior quarter.
- Across five years, Revenue topped out at $924552.0 in Q1 2020 and bottomed at $2342.0 in Q2 2024.
- Historically, Revenue has averaged $282853.0 across 5 years, with a median of $221732.0 in 2021.
- The sharpest annual moves came in 2023 and 2024: Revenue surged 36.75% in 2023, then sank 98.87% in 2024.
- Over 5 years, Revenue stood at $320794.0 in 2020, then dropped by 14.07% to $275653.0 in 2021, then surged by 32.8% to $366068.0 in 2022, then tumbled by 33.12% to $244812.0 in 2023, then slumped by 99.04% to $2342.0 in 2024.
- According to Business Quant data, Revenue over the past three periods registered $2342.0, $117029.0, and $244812.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 1.44 Mn |
| 10 | Soligenix | 6.00 Mn | 6.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 2,342.00 |
| Mar 31, 2024 | 117,029.00 |
| Dec 31, 2023 | 244,812.00 |
| Sep 30, 2023 | 130,440.00 |
| Jun 30, 2023 | 206,929.00 |
| Mar 31, 2023 | 257,178.00 |
| Dec 31, 2022 | 366,068.00 |
| Sep 30, 2022 | 166,140.00 |
| Jun 30, 2022 | 228,640.00 |
| Mar 31, 2022 | 188,063.00 |
| Dec 31, 2021 | 275,653.00 |
| Sep 30, 2021 | 186,198.00 |
| Jun 30, 2021 | 214,824.00 |
| Mar 31, 2021 | 147,593.00 |
| Dec 31, 2020 | 320,794.00 |
| Sep 30, 2020 | 608,811.00 |
| Jun 30, 2020 | 505,288.00 |
| Mar 31, 2020 | 924,552.00 |
| Dec 31, 2019 | 685,261.00 |
| Sep 30, 2019 | 1.25 Mn |